Conclusions: Bariatric surgery is not a guarantee of successful weight loss and maintenance . increasingly, patients regain weight, especially those undergoing restrictive surgeries such as laparoscopic banding rather than malabsorptive surgeries such as Roux-en-Y bypass . active nutritional patient education and clinical management to prevent and detect nutritional deficiencies are recommended for all patients undergoing bariatric surgery . Management of potential nutritional deficiencies is particularly important for patients undergoing malabsorptive procedures, and strategies should be employed to compensate for food intolerance in patients who have had a malabsorptive procedure to reduce the risk for clinically important nutritional deficiencies . To enhance the transition to life after bariatric surgery and to prevent weight regain and nutritional complications, all patients should receive care from a multidisciplinary team including an experienced primary care physician, endocrinologist, or gastroenterologist and consider enrolling postoperatively in a comprehensive program for nutrition and lifestyle management . Future research should address the effectiveness of intensive postoperative nutritional and endocrine care in reducing morbidity and mortality from obesity-associated chronic diseases . 1.1. We recommend that a technically proficient surgical team, preferably accredited by a national certifying organization and an integrated medical support team able to provide dietary instruction and behavior modification be available postoperatively and during long-term follow-up (1| ) .
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1.2. We recommend that treatment of WR postoperatively should include a multidisciplinary approach to medical weight loss, including diet instruction, increased activity, behavior modification, and pharmacological therapy (1| ) .
1.3. We suggest, in cases of severe or unremitting postoperative weight gain, the determination of whether the surgical manipulation of the gastrointestinal tract remains anatomically intact [e.g. absence of gastrogastric fistula after Roux-en-Y gastric bypass (RYGB), integrity of band after a restrictive procedure] . if not intact, a multidisciplinary team should consider all options, including patient education, behavior modification, additional weight loss therapies, or referral for revisionary surgery as clinically indicated (2| ) .
Postoperative nutritional management
2.1. We recommend that nutritional management should include: an average of 60-120 g of protein daily in all patients to maintain lean body mass during weight loss and for the long term . This is especially important in those treated with malabsorptive procedures to prevent protein malnutrition and its effects (1| ) .
2.2. We recommend that long-term vitamin and mineral supplementation be considered in all patients undergoing bariatric surgery, with those who have had malabsorptive procedures requiring potentially more extensive replacement therapy to prevent nutritional deficiencies (1| ) .
2.3. We recommend periodic clinical and biochemical monitoring (see Table 2 ) for micro-and macronutritional deficiencies after bariatric surgery (1| ) .
Management of diabetes mellitus and lipids
3.1. We recommend that postoperative glycemic control should consist of achieving glycated hemoglobin (Hba1c) of 7% or less, with fasting blood glucose no greater than 110 mg/dl and postprandial glucose no greater than 180 mg/dl (1| ) .
3.2. We suggest that physicians and floor nurses be familiar with glycemic targets and insulin protocols, as well as the use of dextrose-free iv fluids and low-sugar liquid supplements (2| ) .
3.3. We recommend that obese patients with type 1 diabetes receive scheduled insulin therapy during their hospital stay, as required (1| ) .
3.4.
We recommend that lipid abnormalities should be treated according to the national Cholesterol education Program (nCeP) guidelines [adult Treatment Panel iii (aTP iii)] and that existing lipidlowering therapy for low-density lipoprotein (ldl)-cholesterol and triglyceride values should be continued after surgery if levels remain above desired goals (1| ) .
Bone health and gout
4.1. We recommend that patients who have undergone malabsorptive [i.e. RYGB, gastric sleeve (Gs), biliopancreatic diversion (BPd)] obesity surgical procedures should have vitamin d, calcium, phosphorus, PTH, and alkaline phosphatase levels followed every 6 months and have a dual-energy x-ray absorptiometry for bone density performed yearly until stable (1| ) .
4.2.
We recommend vitamin d and calcium supplementation postoperatively for malabsorptive obesity surgical procedures and that the doses are adjusted by a qualified medical professional based on serum markers and measures of bone density (1| ) .
4.3.
We suggest that patients with frequent attacks of gout should have prophylactic therapy to lessen the chance of acute gout postoperatively as they lose weight (2| ) .
5 5.0. Gastroenterological and eating behavior considerations 5.1. We recommend that bariatric surgery patients should sip fluids in the immediate postoperative period when fully awake after surgery and that they can only be discharged if satisfactorily tolerating oral fluids (1| ).
5.2. Particularly after procedures with a gastric restrictive component, we recommend that gradual progression of food consistency over weeks to months be used to allow patients to adjust to a restrictive meal plan and to minimize vomiting, which can damage surgical anastamoses or lead to gastroesophageal reflux after restrictive procedures (1| ).
5.3.
We suggest continuous reinforcement of new nutritional habits that discourage the intake of simple carbohydrate-dense foods and beverages, to minimize the frequency of bothersome gastrointestinal symptoms due to dumping, including abdominal pain and cramping, nausea, diarrhea, lightheadedness, flushing, tachycardia, and syncope (2| ).
5.4.
We suggest that patients, who present with postprandial symptoms of hypoglycemia, particularly neuroglycopenic symptoms, should undergo further evaluation for the possibility of insulin-mediated hypoglycemia (2| ).
Method of developMent of evidence-Based RecoMMendations
The Clinical Guidelines Subcommittee of The Endocrine Society deemed endocrine and nutritional management of the post-bariatric surgery patient a priority area in need of practice guidelines and appointed a Task Force to formulate evidence-based recommendations. The Task Force followed the approach recommended by the Grading of Recommendations, Assessment, Development, and Evaluation group, an international group with expertise in development and implementation of evidence-based guidelines. The Task Force used the best available research evidence that members identified to inform the recommendations and consistent language and graphical descriptions of both the strength of a recommendation and the quality of evidence. To indicate the strength of the recommendation, strong recommendations use the phrase "we recommend" and the number 1, and weak recommendations use the phrase "we suggest" and the number 2. Cross-filled circles represent the quality of the evidence, such that denotes very low quality evidence; , low quality;
, moderate quality; and , high quality. The Task Force has confidence that patients who receive care according to the strong recommendations will derive, on average, more good than harm. Weak recommendations require more careful consideration of the patient's circumstances, values, and preferences to determine the best course of action.
Linked to each recommendation is a description of the evidence, the values that panelists considered in making the recommendation (when making these explicit was necessary), and remarks, a section in which panelists offer technical suggestions for testing conditions, dosing, and monitoring. These technical comments reflect the best available evidence applied to a typical patient. Often, this evidence comes from the unsystematic observations of the panelists and should, therefore, be considered suggestions.
intRoduction
The incidence of severe obesity has increased more rapidly than the incidence of non-severe obesity. Between 1999 and 2004, obesity increased by 24% in the United States, whereas the incidence of severe obesity is rising even more rapidly (1). Bariatric surgery has gained wide acceptance as a treatment for severe obesity, especially when complicated by type 2 diabetes mellitus (T2DM). An estimated 200,000 operations were performed in 2009 alone at a cost of about $5 billion. After surgery, patients are cared for by their primary care physicians, endocrinologists, or gastroenterologists. Frequently, these patients present also aid in the prevention of WR by keeping patients focused on lifestyle issues over the long term, but this has not been demonstrated in clinical trials . in addition, the facility where the surgeon practices must have experience with bariatric patients and a familiarity with routine postoperative care .
Physicians referring patients to bariatric surgery should request specific experience and performance data from the bariatric surgeon or program regarding the procedure being considered . Various resources are available to locate a suitable bariatric surgeon on the internet or by contacting the surgical Review Corporation, american society for Metabolic and Bariatric surgery, american College of surgeons, or the Obesity society . These resources should be a starting point for finding surgeons to work in a collaborative fashion with endocrinologists, gastroenterologists, and primary care physicians interested in the postoperative care of patients after bariatric surgery . Common operations include various banding procedures, which restrict the amount of food entering the stomach, the RYGB, the duodenal switch (ds)/Gs, or the BPd (Fig . 1) . The modifications of gastrointestinal function after these surgeries are least with banding, greater with RYGB, and greatest with BPd or ds/Gs . as the physiological alterations of gastrointestinal function increase, there is an impression that less medical, dietary, and behavioral intervention is needed to induce weight loss . Pure restrictive operations such as adjustable gastric banding are more commonly associated with WR and weight loss failure than techniques with a malabsorptive component such as RYGB . However, the use of routine algorithms in postoperative care is essential to reduce the risk of WR and postoperative complications . WR is not uncommon in patients undergoing bariatric surgery, and it can be expected that 20-25% of the lost weight will be regained over a period of 10 yr . The impact of this WR on comorbid conditions is dependent on individual risk factors . The vast majority of long-term studies after either pure restrictive or mixed techniques show WR (2-5), which in some cases may lead to a percentage of excess weight loss lower than 50% (5-7) . although WR prevalence has been reported in 7-50% of cases (7, 8), this classification as WR is based on an arbitrary amount of WR (50% of the lost weight) . On the other hand, loss of patients to follow-up at late stages may underestimate the true prevalence of WR . significant WR is accompanied by reversal or reduction of surgically improved obesity comorbidities, including common medical conditions and psychosocial functioning, which may lead to a decrease in quality of life (3, 9) .
PrEvENTiON ANd TrEATMENT Of Wr

Causes of WR
WR is most commonly related to noncompliance with dietary and lifestyle instructions, although differences in physiological responses and occasionally surgical failure can be the cause (Table 1) . Food records show that calorie intake is reduced after bariatric surgery, but increases at 1-2 yr after surgery coincide with WR (3) . in general, patients report greater physical activity over the long term compared 
Prevention and treatment of WR
Prevention of WR is essential to maintain the benefits of bariatric surgery on a long-term basis . Key factors are preoperative realistic expectations, adherence to scheduled visits (27), compliance with nutritional recommendations, maintenance of regular physical activity of at least 150 min/wk (28), and periodic assessment to prevent or treat eating or other psychiatric disorders (27, 29) . in general, bariatric surgery has a favorable impact on psychological condition (30, 31), although some improvements may disappear over time . From the nutritional point of view, a low glycemic load, moderately high protein content diet, combined with a physical activity program has been shown to effectively treat WR in the short term (32) . Promoting adherence to diet and lifestyle recommendations by collecting food records and monitoring body weight carefully is also useful . Participation in support groups could also be helpful in the prevention and treatment of WR (33, 34) .
Because patients with a mechanically intact malabsorptive operation who have experienced WR are not likely to achieve sustained weight loss after pouch revision, revisional surgery is inadvisable for them (35) . When WR is severe and unremitting, consideration should be given to revisional bariatric surgery, and this should be discussed with a surgeon experienced in revisional surgery . in some cases, RYGB or ds (36, 37) can be indicated after failure of a previous restrictive operation . nevertheless, application of conventional strategies and the risk of serious postoperative complications must be carefully evaluated before making this decision (36) .
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protein needs are constant across all energy intakes . so at low energy intake, protein needs to be a higher percentage of total calories, and at high energy intake, protein can be reduced as a percentage of total calories . in general, dietary protein should be established first in any diet in proportion to body weight, and then carbohydrates and fats should be added as determined by energy needs . Protein is an important part of good nutrition at every meal . Vitamins and minerals can fulfill nutrient needs on a once-per-day basis, but for protein, the body has no ability to store a daily supply . To maintain healthy muscles and bones for adults, at least 30 g of protein should be consumed at more than one meal . Breakfast is an important meal for dietary protein because the body is in a catabolic state after an overnight fast . a meal with at least 30 g protein is required to initiate repletion of body proteins . Protein at breakfast is also critical for regulation of appetite and daily food intake . The recommended dietary allowance represents the minimum daily intake for active healthy adults . For most adults, replacing some dietary carbohydrates with protein will help to maintain body composition and mobility, studies have found only a 0-6% incidence of protein deficiency after RYGB up to 43 months postoperatively (46-48) . Protein malnutrition causes an annual hospitalization rate of 1% per year after malabsorptive procedures and leads to significant morbidity (42, 49) .
When it occurs, protein malnutrition is generally observed at 3-6 months after surgery and is largely attributed to the development of food intolerance to protein-rich foods (50 The multivitamin-mineral preparations should have the recommended daily requirements for vitamins and minerals . initially, one to two tablets of a chewable preparation are advised because they are better tolerated after malabsorptive procedures . However, nonchewable preparations or products with fortified amounts of folic acid and iron, such as prenatal vitamins, can be used .
Vitamin B12 deficiencies can occur after bariatric surgery procedures that bypass the lower stomach . impairment of vitamin B12 absorption after RYGB results from decreased digestion of the protein-bound cobalamins and impaired formation of intrinsic factor-vitamin B12 complexes required for absorption (57, 70-72) . according to one study, 30% of RYGB patients receiving only a multivitamin supplement will have a B12 deficiency after 1 yr (73) . in other studies, the incidence of vitamin B12 deficiency after RYGB is 33-40% at postoperative yr 1 (74) and 8-37% by yr 2-4 (48, 60, 75, 76) . in a study of vertical banded gastroplasty patients (n=26), there were no instances of vitamin B12 deficiency at 1 yr (77) . anemias as a result of vitamin B12 deficiency have improve blood lipids and lipoproteins, and help to control food intake (52-55) .
Modular protein supplements can be sorted into four categories: 1) protein concentrates derived from a complete protein such as milk, soy, or eggs; 2) protein concentrates derived from collagen, either alone or in combination with a complete protein; 3) doses of one or more dispensable (nonessential) amino acids; and 4) hybrids of the complete or collagen-based proteins and amino acid dose . Modular protein supplements are generally provided either as a substrate for protein synthesis or as a source of one or more amino acids that may be conditionally indispensable (conditionally essential) (50) .
Hospitalization with initiation of parenteral nutrition support may be required (38) in cases of severe protein deficiency, but there are no currently accepted guidelines or clinical studies guiding nutritional therapy after weight loss surgery . nutritional support with parenteral nutrition for at least 3-4 wk may rarely be required after RYGB when enteral nutrition is not successful (56) . Caution must be exercised with the initiation of solutions containing high amounts (>100-200 g/d) of dextrose in the setting of severe malnutrition to avoid refeeding syndrome . symptoms of refeeding syndrome include swelling with signs of volume overload associated with hypokalemia, hypophosphatemia, and hypomagnesemia . This constellation of clinical features results from the insulin-mediated influx of electrolytes into cells and renal salt and water retention (57) . if a patient requires prolonged parenteral nutrition, then surgical revision and lengthening of the common channel to decrease malabsorption is warranted (41), although this will increase the likelihood of WR .
Vitamin and mineral supplementation
The anatomic changes imposed by malabsorptive surgery increase the risk for various vitamin and mineral deficiencies, which can occur commonly within the first year after surgery (42, 43, 48, 58-62) . after RYGB, screening and supplementation of deficiencies with a multivitamin-mineral, iron, vitamin B12, or calcium with vitamin d is routinely conducted, and prophylactic supplementation should be considered in patients consumed in the presence of calcium supplements or with dairy products . Calcium at doses of 300-600 mg has a direct dose-related inhibiting effect on iron absorption . This has been seen with calcium carbonate, calcium citrate, and calcium phosphate . The risk for iron deficiency increases over time, with some series reporting that more than half of subjects had low ferritin levels 4 yr after the RYGB, BPd, or BPd/ds (48) . iron deficiency after RYGB is influenced by multiple factors and can persist to 7 yr postoperatively (93) . iron deficiency has been reported to occur in up to 50% of patients after RYGB, most frequently in women with menorrhagia (63, 64) . Thus, empiric iron supplementation is recommended (84, 85) . in a randomized, controlled trial, iron supplementation (65 mg elemental iron by mouth twice daily) prevented the development of iron deficiency, although it did not always prevent the development of anemia (85), suggesting that in some subjects after RYGB, anemia may be related to factors other than iron deficiency . supplementation with lower doses (80 mg/d) does not universally prevent iron deficiency (48) . Vitamin C increases iron absorption and should be included empirically with iron supplementation (65, 84) . Because oral iron supplementation is associated with poor absorption and adverse gastrointestinal effects, and im injections are painful, intermittent iv iron infusion may be required during treatment . iron dextran, ferric gluconate, or ferric sucrose may be administered iv . supplementation should follow currently accepted guidelines to normalize hemoglobin (85), and continued surveillance of hemoglobin and iron studies is recommended .
steatorrhea induced by malabsorptive surgical procedures can lead to deficiencies in fat-soluble vitamins, which typically present as an eczematous rash (38, 42, 49) . Vitamin a deficiency after bariatric surgery results from poor nutritional intake, maldigestion, malabsorption, and impaired hepatic release of vitamin a . in two series, the incidence of vitamin a deficiency was 61-69% 2-4 yr after BPd, with or without ds (40, 94) . in a third series, the incidence was as low as 5% by 4 yr (62) . although data are scarce, mild vitamin a deficiency can also occur after distal RYGB procedures and is easily corrected with oral supplementation (62) .
Oral supplementation of vitamin a, 5,000-10,000 been reported to occur in more than 30% of patients 1-9 yr after RYGB (42, 78) . Thiamine deficiency can occur as a result of bypass of the jejunum, where thiamine is primarily absorbed, or as a result of impaired nutritional intake from recurrent emesis(96,97) . acute neurological deficits as a result of thiamine deficiency have been reported as soon as 1-3 months after surgery (98-107) . early recognition is paramount to initiate appropriate supplementation and to avoid potential complications resulting from the administration of dextrosecontaining solutions (108) . although not often evaluated, thiamine status is best assessed by determining erythrocyte transketolase activity . Parenteral supplementation with thiamine (100 mg/d) should be initiated in the patient with active neurological symptoms (109, 110) . after a 7-to 14-d course, an oral preparation (10 mg/d) can be used until neurological symptoms resolve (56, 111, 112) . severe thiamine deficiency most commonly occurs in patients who develop severe, intractable vomiting after bariatric surgery, usually due to a mechanical problem such as stomal stenosis after RYGB excessive band tightness or slippage after laparoscopic aGB (laGB) . it is important that persistent vomiting be resolved aggressively to prevent this devastating complication .
Biochemical and clinical monitoring
The extent of metabolic and nutritional evaluation completed after bariatric surgery should be guided by the surgical procedure performed . Purely gastric restrictive procedures are not associated with alterations in intestinal continuity and do not alter normal digestive physiology . as a result, selective nutritional deficiencies are uncommon .
3.4.
We recommend that lipid abnormalities should be treated according to the nCeP guidelines (aTP iii) and that existing lipid-lowering therapy for ldl-cholesterol and triglyceride values should be continued after surgery if levels remain above desired goals (1| ) .
3.1.-3.4. Evidence Type 2 diabetes mellitus
T2dM is commonly associated with severe obesity but can improve to the point that little or no medication is necessary in patients after RYGB (121) (122) (123) . Fasting plasma glucose concentrations have been reported to return to normal before hospital dismissal and before significant weight loss (124) (125) (126) (127) (128) (129) (130) (131) (132) (133) (134) (135) (136) (137) . after RYGB or BPd/ds/ Gs, insulin-treated patients experience a significant decrease in insulin requirements; the majority of patients can discontinue insulin therapy by 6 wk after surgery (136, 138) , and some may even be able to discontinue insulin before hospital discharge . The long-term effects of these
MANAGEMENT Of diABETES MElliTuS ANd liPidS
Recommendations 3.1. We recommend that postoperative glycemic control should consist of achieving glycated Hba1c of 7% or less with fasting blood glucose no greater than 110 mg/dl and postprandial glucose no greater than 180 mg/dl (1| ) .
3.2. We suggest that physicians and floor nurses be familiar with glycemic targets and insulin protocols as well as the use of dextrose-free iv fluids and low-sugar liquid supplements (2| ) .
3.3. We recommend that obese patients with type 1 diabetes receive scheduled insulin therapy during their hospital stay, as required (1| ) . Physicians and floor nurses should be familiar with glycemic targets and insulin protocols as well as with the use of dextrose-free iv fluids and low-sugar liquid supplements . Parameters for starting iv insulin should follow established clinical protocols . Patients should be instructed on regular monitoring of metered blood glucose concentrations to guide adjustments in glucose-lowering therapy . in the patient with persistent hyperglycemia, continued surveillance and preventive care as recommended by the american diabetes association are advised . sulfonylurea drugs should generally be avoided in the immediate postoperative period when insulin sensitivity may improve and increase the risk of hypoglycemia . These agents should be reintroduced later only if clinically indicated . The long-term management of patients who achieve remission of their T2dM after surgery is not established, but routine follow-up should be continued .
bypass operations appear to include both weight lossdependent and -independent effects (139) .
By contrast, gastric restrictive operations such as banding appear to improve T2dM as a result of the weight loss itself . Therefore, the effects will likely be reversed if there is WR (140) .
The longer T2dM has been present, the less likely it is to respond to surgically induced weight loss (124, 126) , most likely due to destruction of pancreatic beta-cells . Whether weight loss and/or bypass surgery itself will also slow the cellular and molecular events leading to beta-cell destruction in the long term has not been established .
improvements in hyperglycemia are observed almost immediately after RYGB, in part due to increased release of GlP-1 (141-143) and possibly other incretins . Rubino and Gagner (144) observed that RYGB and BPd achieved durable primary beneficial effects on glycemic control in 80-100% of patients with T2dM, independent of effects on body weight . These conclusions were supported by rat studies in which gastrojejunal bypass controlled T2dM independent of weight loss (145) . in a subsequent study of 10 obese patients undergoing RYGB, a potential mechanism was elucidated (136) . Bypass of the proximal small bowel was associated with a statistically significant increase in GlP-1 and hyperinsulinemia . Moreover, early presentation of undigested food to the distal small bowel was associated with a trend toward greater levels of GlP-1 and restoration of normal glucosestimulated insulin secretion (136) . These and/or other intestinal factors may also restore meal-induced suppression of ghrelin release from the stomach, resulting in decreased food intake (146) . One explanation for the immediate effects of RYGB and intestinal bypass on glucose metabolism is that secretion of incretins, including glucose-dependent insulinotropic polypeptide and GlP-1, recovers rapidly after surgery . Bypass of the duodenum without gastric bypass or ileal interposition has been found to improve diabetes in both animal models and patients (136, 143, 147) . although these changes in glucose homeostasis may play a physiological role, more research is needed to determine their contribution to glucose control under real-world conditions of rapid weight loss after RYGB .
taken to rule out esophageal or gastric varices and/or need for transplantation (158), and liver transplant patients may undergo successful bariatric surgery (167) . naFld is being increasingly recognized as an important cause of liver-related morbidity and mortality (168) and may be the most common cause of cryptogenic cirrhosis in the obese patient (169) . abnormal transaminases should be followed at appropriate intervals until they fall into the normal range or stabilize .
Lipid disorders
Triglyceride and ldl-cholesterol decrease and high-density lipoprotein-cholesterol increases after laGB, RYGB, BPd, or BPd/ds surgery (170-183) . However, conventional lipid measurements of total and ldl-cholesterol may not be reflective of dyslipidemic risks and/or insulin resistance in obese people, as suggested by a cross-sectional study of 572 obese patients (184) . The improvement in dyslipidemia appears to be related not only to the percentage of excess weight loss (170) but also to the decrease in insulin resistance (170) . Given the improvement in cardiovascular mortality after bariatric surgery, these changes have likely led to a decreased risk of cardiovascular disease . Recent studies show decreased cardiovascular and myocardial infarction mortality in bariatric surgery patients (185) . Previously unrecognized lipid abnormalities may be identified and can strengthen the case for medical necessity for these procedures . lipid abnormalities should be treated according to the nCeP guidelines (186) . lipidlowering therapy for ldl-cholesterol and triglyceride values that remain above desired goals after surgery should be continued . BPd and BPd/ds procedures have been associated with lower triglyceride and ldl values (128) . due to the dramatic reductions in lipid levels, the doses of lipid-lowering drugs should be periodically reevaluated .
Postoperative pregnancies
Women with a history of oligomenorrhea and androgenicity due to polycystic ovarian syndrome may become fertile during the postoperative period and should be counseled that unexpected pregnancies can occur unless contraceptive methods are employed . The management of pregnancy requires meeting the nutritional needs of a pregnant mother with attention to micronutrients and protein . We generally recommend that patients take precautions to avoid pregnancy for 12 to 18 months after surgery . Rates of many adverse maternal and neonatal outcomes may be lower in women who become pregnant after having had bariatric surgery compared with rates in pregnant women who are obese; however, further data are needed from rigorously designed studies (153) .
Fatty liver disease and nonalcoholic fatty liver disease (NAFLD)
Many obese patients will have abnormal liver function tests with asymptomatic increases in serum alanine aminotransferase and aspartate aminotransferase . These changes are most commonly associated with fatty liver disease or naFld . at the time of surgery, 84% of severely obese subjects have steatosis on liver biopsy specimens (154), whereas 20 and 8% have inflammation and fibrosis, respectively . Weight loss after laGB, RYGB, BPd, or BPd/ds leads to regression of steatosis and inflammation, including decreased bridging fibrosis in some cases (155-164) . The clinical challenge is to determine which patients require additional evaluation, because fatty liver disease is a diagnosis of exclusion . Gallstones, chronic hepatitis B or C, alcohol use, and potential side effects of medications (such as acetaminophen, nonsteroidal inflammatory agents, and clopidogrel) are among the less common causes of liver disease . Patients with marked increases in liver function tests (generally considered at two to three times the upper limit of normal) should be considered for additional testing by hepatobiliary ultrasonography or computed tomography, and a hepatitis screen if this was not done before surgery (165 at present, there are no conclusive data regarding the association of altered calcium and vitamin d homeostasis with laGB surgery . in two reports, laGB was not associated with significant reduction in bone mineral density (208, 209) . Calcium deficiency and metabolic bone disease can occur in RYGB patients (55, 62, 206, 210, 211) . The onset of metabolic bone disease is insidious and results from a decrease in the intake of calcium-rich foods, bypass of the duodenum and proximal jejunum where calcium is preferentially absorbed, and malabsorption of vitamin d (56, 63, 207, 212) .
a rise in serum intact PTH indicates negative calcium balance and/or a vitamin d deficiency . elevations of bone-specific alkaline phosphatase and osteocalcin levels, which indicate increased osteoblastic activity and bone formation, are often the initial abnormalities found (63, 207) . The appropriate use of bone turnover markers has been proposed as a useful screening tool for metabolic bone disease after RYGB because serum calcium and phosphate levels are often normal, but this has not been established (56, 207, 212, 213) .
BONE hEAlTh ANd GOuT
Recommendations 4.1. We recommend that patients who have undergone malabsorptive (i.e. RYGB, Gs, and BPd) obesity surgical procedures should have vitamin d, calcium, phosphorus, PTH, and alkaline phosphatase levels followed every 6 months and have a dual-energy x-ray absorptiometry for bone density performed yearly until stable (1| ) .
4.2. We recommend vitamin d and calcium supplementation postoperatively for malabsorptive obesity surgical procedures and that the doses be adjusted by a qualified medical professional based on serum markers and measures of bone density (1| ) .
4.3.
4.1.-4.3. Evidence
Obesity is associated with greater bone density, but weight loss by diet or other means decreases bone density . Bone loss is accompanied by an increase in bone turnover, but only malabsorptive procedures cause a disproportionate loss of bone compared with weight loss through dietary calorie restriction .
The Roux-en-Y procedure is the leading bariatric operation performed in the united states . in this surgery, the primary sites for calcium absorption are bypassed . Patients become calcium-and vitamin d-deficient, and the body then up-regulates PTH, causing increased production of vitamin d and increased calcium resorption from bone . Gastric banding uses a restrictive band and has not been shown to produce the same bone loss as the Roux-en-Y procedure, nor has there been evidence of secondary hyperparathyroidism (187-199) .
Overall, after a malabsorptive bariatric procedure, 10-25% of patients develop a calcium deficiency by 25-d levels normalize . Primary treatment is with ergocalciferol, but in individuals with persistently elevated PTH levels or bone loss, calcitriol (1,25-d) therapy has been used in this setting . However, appropriate use has not been established . intravenous (0 .25-0 .5 mg/d) or oral (0 .25-1 .0 mg daily or twice daily) calcitriol therapy has been used in situations characterized by symptomatic hypocalcemia and severe vitamin d malabsorption . Many obese patients have suboptimal levels of vitamin d, and it is important to normalize vitamin d levels preoperatively when the procedure contemplated is likely to result in vitamin d malabsorption . However, in asymptomatic patients in whom 25-d levels fail to reach optimal levels (25-d 30 ng/ml), functionally normalize 1,25-d levels, and suppress elevated PTH levels, the use of calcitriol is unproven . adequate calcium and vitamin d supplementation has been achieved when levels for serum calcium, bone-specific alkaline phosphatase or osteocalcin, 25-d, and 24-h urinary calcium excretion rates are normal . PTH levels may persist above the normal range, even with functionally replete vitamin d levels (25-d > 30 ng/ml) . Monitoring of vitamin d and PTH levels should be accompanied by monitoring of calcium . if elevated calcium levels are found, then PTH levels should be measured to detect primary hyperparathyroidism . in most bariatric surgery patients, there will be secondary hyperparathyroidism secondary to negative calcium balance as indicated rather than primary hyperparathyroidism .
Obese patients with a body mass index greater than 40 kg/m 2 are at greater risk for osteoarthritis, progression of arthritis, and gout, which can improve with weight loss (224) . after bariatric surgery, hip and knee pain may improve, and exercise capacity may increase (225) (226) (227) (228) . Moreover, serum uric acid levels decrease (81) . Gout may be precipitated during weight loss after intestinal bypass (211), just as surgery itself is a risk factor for acute gout attacks . Therefore, patients with frequent attacks of gout should have prophylactic therapy started well in advance of surgery to lessen the chance of acute gout immediately after surgery . after gastric restrictive procedures, urinary C-telopeptide levels, indicative of increased bone resorption, are elevated (213) . in the event of prolonged immobilization after laGB or RYGB, increased bone resorption, especially in association with critical illness, might be associated with hypercalciuria and, if renal calcium excretion is impaired, frank hypercalcemia (214) . Rapid and extreme weight loss is associated with bone loss (215) (216) (217) , even in the presence of normal vitamin d and PTH levels (213) .
decreased weight-bearing after surgery may also contribute to bone loss and can be estimated with n-or Ctelopeptide levels (213) . after a malabsorptive bariatric procedure, patients might have continued secondary hyperparathyroidism, low 25-d levels, increased 1,25-dihydroxyvitamin d (1, 25-d) levels, and hypocalciuria (67, 207, 210, 211, 213, 218) . left uncorrected, secondary hyperparathyroidism will promote bone loss and increases the risk for osteopenia and osteoporosis (210) . The presence of hypocalcemia in the setting of vitamin d deficiency exacerbates mineralization defects and accelerates the development of osteomalacia (219) . in an observational study by diniz Mde et al. (220) , 29% of patients developed secondary hyperparathyroidism and 0 .9% hypocalcemia beyond RYGB postoperative month 3 . Parada et al. (221) reported that 53% of patients had secondary hyperparathyroidism after RYGB . Youssef et al. (222) found a greater degree of secondary hyperparathyroidism and vitamin d deficiency with longer Roux limb length after RYGB .
Riedt et al. (223) found that women who have had a RYGB experienced decreased estradiol-and vitamin d-dependent intestinal calcium absorption . This was associated with increased n-telopeptide (marker of bone resorption), increased osteocalcin (marker of bone formation), or an uncoupling effect on bone remodeling (223) . Compston et al. (60) found an increased incidence of metabolic bone disease with standard BPd and a 50-cm common channel, but without reduced serum 25-d levels . after bariatric surgery, the most common cause of secondary hyperparathyroidism with normal vitamin d levels is calcium deficiency . a common regimen consists of weekly parenteral ergocalciferol, 100,000 iu, until
GASTrOENTErOlOGiCAl ANd EATiNG BEhAviOr CONSidErATiONS
Recommendations 5.1. We recommend that bariatric surgery patients should sip fluids in the immediate postoperative period when fully awake after surgery and that they can only be discharged if satisfactorily tolerating oral fluids (1| ) .
5.2.
Particularly after procedures with a gastric restrictive component, we recommend that gradual progression of food consistency over weeks to months be used to allow patients to adjust to a restrictive meal plan and to minimize vomiting, which can damage surgical anastamoses or lead to gastroesophageal reflux after restrictive procedures (1| ) .
5.3.
We suggest continuous reinforcement of new nutritional habits that discourage the intake of simple carbohydrate-dense foods and beverages to minimize the frequency of bothersome gastrointestinal symptoms due to dumping, including abdominal pain and cramping, nausea, diarrhea, lightheadedness, flushing, tachycardia, and syncope (2| ) .
5.4. We suggest that patients who present with postprandial symptoms of hypoglycemia, particularly neuroglycopenic symptoms, should undergo further evaluation for the possibility of insulin-mediated hypoglycemia (2| ) .
5.1.-5.4. Evidence Vomiting and surgical complications
Chronic vomiting, generally described by the patient as spitting up or the food gets stuck, can occur . One third to two thirds of patients report postoperative vomiting (229) (230) (231) . Vomiting is thought to occur most commonly during the first few postoperative months (232) , when the patients are adapting to a small gastric pouch . This vomiting is not believed to be a purging behavior as seen with bulimia nervosa .
instead, patients may vomit in response to intolerable foods or in an effort to clear food that has become lodged in the upper digestive tract . Frequent vomiting may suggest: 1) obstruction, necessitating evaluation with a gastrointestinal contrast study, before any endoscopic procedure in laGB patients; 2) reflux, inflammation, stoma erosion/ulceration, or stenosis, necessitating endoscopy; or 3) gastric dysmotility, necessitating a radionuclide gastric-emptying study .
Regurgitation that occurs after a laGB can be managed with appropriate band adjustments and nutritional advice .
Continuous reinforcement of new nutritional habits will help minimize the frequency of bothersome gastrointestinal symptoms . Guidance remains important to optimize nutritional intake in patients who have had a mal-absorptive procedure because of the risk for clinically important nutritional deficiencies (233) . For surgeries with a gastric restrictive component, regular visits with the clinical team provide guidance as the meal plan is progressed . The limited volume capacity of the gastric pouch (30-60 ml) results in marked restrictions in the amount and rate at which food can be eaten . during the first few months after surgery, episodes of regurgitation, typically without nausea or true vomiting, are common if food is consumed in large volumes or too quickly or if it is not chewed thoroughly .
RYGB has been associated with staple line failure (234, 235) and a stomal ulceration rate of up to 16% (234, 236) . staple line disruption and gastrogastric fistulas can also occur after gastric transection and increase the risk of marginal ulceration (234, 237) . More recent stapling techniques only rarely result in staple line failure, although there is no clear guidance regarding the optimal stapling method .
late surgical complications include anastomotic stricture, staple line dehiscence, pouch dilation, internal hernia with intestinal obstruction (complete or partial), anastomotic leaks, and incisional hernias (41, 238) . an internal hernia after RYGB, BPd, or BPd/ ds is a potentially fatal complication secondary to bowel infarction and peritonitis . The symptoms are those of a small bowel obstruction with cramping pain, usually periumbilical . There are three locations for an late dumping can be due to reactive hypoglycemia and can often be managed with nutritional manipulation or be treated prophylactically by having the patient eat a small snack .
Postprandial hypoglycemia
Post-RYGB patients who present with postprandial symptoms of hypoglycemia, particularly neuroglycopenic symptoms, should undergo further evaluation for the possibility of insulin-mediated hypoglycemia . in a study conducted in one institution, only nine adult patients without a history of gastric bypass had surgically confirmed nesidioblastosis during the same period in which six patients were evaluated and treated for the condition after gastric bypass surgery (GBs) (245) . The study described six patients with severe, intractable postprandial symptoms associated with endogenous hyperinsulinemic hypoglycemia . This complication, believed to be secondary to the RYGB anatomy in some patients, has necessitated partial pancreatectomy for relief of the symptoms and hypoglycemia . in these patients, histological examination demonstrated pancreatic islet cell hyperplasia . This complication may present from 2 to 9 yr after RYGB . in a recent study of 14 patients with hyperinsulinemic hypoglycemia, the glucose and insulin responses to mixed meals were measured (246) . a subsequent study of six RYGB patients with postoperative hypoglycemia compared with lean and obese controls without hypoglycemia failed to find an increase in beta-cell mass (247) and concluded that post-GBs hypoglycemia is not due to an increase in beta-cell mass or formation . Rather, they concluded that postprandial hypoglycemia after GBs is due to a combination of gastric dumping and inappropriately increased insulin secretion, either as a failure to adaptively decrease insulin secretion after GBs or as an acquired phenomenon (247) .
internal hernia: at the jejunojejunostomy, through the mesocolon, or between the Roux limb mesentery, mesocolon, and the retroperitoneum (Petersen hernia) . diagnosis may be obtained with a gastrografin upper gastrointestinal or abdominal computed tomography; however, as with a leak, these studies are often misleading (41) . in many instances, the best course of management is an exploratory laparotomy or laparoscopy for recurrent cramping abdominal pain .
Dumping syndrome
abdominal pain and cramping, nausea, diarrhea, lightheadedness, flushing, tachycardia, and syncope, indicative of dumping, are reported frequently and serve to discourage the intake of energy-dense foods and beverages (203, 239, 240) . Gastric dumping occurs initially in 70-76% of patients who have had a RYGB (61, 124, 241) . However, the frequency of clinically troublesome complaints is unknown . some reports suggest that the dumping syndrome may not occur in all patients or may occur only transiently during the first postoperative year (242) . For some patients, dumping may be considered to be a desired side effect because it discourages ingestion of calorically dense liquids that could mitigate weight loss . it used to be thought that dumping symptoms were the result of the hyperosmolarity of intestinal contents, which resulted in an influx of fluid into the intestinal lumen with subsequent intestinal distention, fluid sequestration in the intestinal lumen, decreased intravascular volume, and hypotension . More recent data suggest that food bypassing the stomach and entering the small intestine leads to the release of gut peptides that are responsible for dumping symptoms because they can often be blocked with sc octreotide, a somatostatin analog (243) .
dumping symptoms tend to become less prominent with time (240) and can usually be controlled with certain nutritional changes, such as: 1) eating small, frequent meals; 2) avoiding ingestion of liquids within 30 min of a solid-food meal; 3) avoiding simple sugars and increasing intake of fiber and complex carbohydrates; and 4) increasing protein intake (244) . if these measures are unsuccessful, then octreotide, 50 mg sc 30 min before meals may reduce symptoms in some patients (244) .
Suggested directions for future research
due to the nature of the physician-patient relationship in individualizing bariatric surgical approaches, research that compares different types of surgery in a randomized, prospective, controlled design study is challenging . However, it would be possible to design a postoperative study that assigns subjects randomly to standard intervention or intensive intervention to examine effects on WR, morbidity, and mortality . By stratifying the study to examine laparoscopic adjustable banding and RYGB, it would be possible to tailor the interventions to the needs of the two types of operations as restrictive and malabsorptive . it is also possible that this type of research could be applied successfully to more aggressive malabsorptive procedures as long as the appropriate safety standards were incorporated .
Finally, treatment of diabetes and metabolic disease through surgical intervention requires greater study . The scientific rationale for the approach is sound, but questions remain pertaining to long-term outcome and the possible occurrence of nesidioblastosis after gastric bypass . These issues and the impact on overall mortality in diabetes deserve much more attention in future clinical research . 
